Skip to content

Nordic walking to improve functional exercise capacity and daily physical activities in chronic obstructive pulmonary disease (COPD)

Nordic walking to improve functional exercise capacity and daily physical activities in chronic obstructive pulmonary disease (COPD): a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN31525632
Enrollment
60
Registered
2009-04-21
Start date
2006-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease (COPD) Respiratory Other chronic obstructive pulmonary disease

Interventions

The participants were randomised to either the intervention or control group: Intervention group: 12 weeks outdoor Nordic walking exercise programme (1 hour per session, 3 times/week) Control group:

Sponsors

Ludwig Boltzmann Institute for COPD (Ludwid Boltzmann Institut für COPD) (Austria)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Both males and females, age >18 years 2. Stable COPD (no infection or exacerbation for at least 12 weeks) 3. Absence of severe and/or unstable cardiac diseases (myocardial infarction within the last 6 month, cardiac arrhythmia Lown classification >IIIb, as shown by electrocardiogram during rest and maximal exercise test) 4. Absence of other pathologic conditions that could impair daily physical activities (cerebrovascular diseases, rheumatism, symptomatic osteoporosis and others)

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Functional exercise capacity, assessed using the six minute walking test (6MWT). All primary and secondary outcome measures will be assessed at baseline and after 3, 6, and 9 month.

Secondary

MeasureTime frame
1. Daily physical activities, assessed using a tri-axial accelerometer (DynaPort® Activity Monitor; McRoberts BV, Netherlands) 2. Exercise-induced dyspnoea, assessed using the modified Borg Dyspnoea Scale 3. Mood status, assessed using the Hospital Anxiety and Depression Scale (HADS) All primary and secondary outcome measures will be assessed at baseline and after 3, 6, and 9 month.

Countries

Austria

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026